Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
asx companies
Small Caps Stocks Growth Stocks
Here’s How ASX Companies Become 10-Baggers And How Investors Can Identify Top Candidates To Be Next!
Every investor eyeing off ASX companies will desire to find a 10‑bagger. Very few work with a structure that makes it repeatable. Yet these moves are not random. In our experience, they follow a recognisable sequence, and the ASX has offered clean examples over the past year in companies like 4D Medical, Sunrise Energy Minerals…
2 hours ago0Comments
tungsten
Mining Stocks Small Caps Stocks
Tungsten: Its A Metal Whose Moment Has Arrived And These 3 ASX Stocks Are Exposed To It!
Tungsten has quietly become one of the most strategically significant metals in the world. China controls roughly 80% of global supply, yet Beijing has spent the past 18 months systematically restricting exports, and the consequences for Western industrial and defence supply chains are now acute. Prices are at all-time highs, the supply-demand deficit is structural rather…
3 hours ago0Comments
Shares in Dimerix
Biotech Stocks Healthcare Stocks Life Sciences
Shares In Dimerix (ASX:DXB) Fell 40% Today; Not About The Data, But About the Timing
Shares in Dimerix fell over 35% this morning and some may think the decline was irrational. After all, the announcement confirmed >90 per cent statistical power for its primary endpoint, reminded the market that its 2024 futility analysis showed the drug outperforming placebo, and reported no safety issues across seven IDMC reviews. On paper, that…
3 days ago0Comments
Percheron
Biotech Stocks Healthcare Stocks Life Sciences
Percheron Therapeutics (ASX:PER): An Oncology Biotech That’s Growing Its Footprint
Percheron Therapeutics is not the kind of company that typically commands market attention at a A$6–7m valuation. Yet the more one looks at its trajectory over the past twelve months, the more it becomes clear that the market is missing something important. The company has moved from being a near‑dormant shell to a clinical‑stage immuno‑oncology…
3 days ago0Comments
CGT discount on shares
Agriculture Stocks AI Stocks Airlines Bank Stocks Basic Materials Biotech Stocks Blue Chip Stocks Cannabis Stocks CleanTech Consumer Cryptocurrencies Currency Cybersecurity Stocks Defence Stocks Education Energy Stocks ETF EV Stocks Financials Green Investments Growth Stocks Healthcare Stocks International Stocks IPOs Large Caps Life Sciences Mid Cap Stocks Mining Stocks News Penny Stocks Property Real Estate Resources Retail Safe Stocks Semiconductor stocks Small Caps Stocks Steel Stocks Tech Stocks Technology Telecommunications Stocks Travel Stocks Undervalued Stocks
The 50% CGT discount on shares: Here’s how it works, and if it is under threat
The 50% CGT discount on shares is one of the key mechanisms that helps investors keep as much of their cash as they have earned on their investments. We felt that it was time to write a stand-alone article about this in light of the inflation crisis and how it could lead to investors seeking…
3 days ago0Comments
American Express
International Stocks Financials
American Express (NYSE:AXP): A Premium Model in a Changing World – Is It Worth a Look?
American Express (NYSE:AXP) remains one of the most structurally differentiated businesses in global payments. Its premium cardholder base, closed‑loop network, and multi‑layered revenue model continue to give it an economic profile that Visa and Mastercard simply do not share. Berkshire Hathaway's long-standing conviction in the stock is well known, and the company’s recent performance suggests…
3 days ago0Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here